Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packer

Showing results (271-280 of 4,797) with videos related to

Pageof 480
Sort By:
Circulation|October 1, 1985
Sudden unexpected death in patients with congestive heart failure: a second frontierM Packer
Journal of Cardiovascular Pharmacology and Therapeutics|June 23, 2017
Response by Dr Packer to the Letter of Dr BlankfieldMilton Packer
Circulation. Cardiovascular Quality and Outcomes|April 7, 2018
Does a Target Dose or a Target Heart Rate Matter to Outcomes When Prescribing β-Blockers to Patients With Chronic Heart Failure?Milton Packer
Circulation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM Packer
European Heart Journal|June 26, 2018
Questioning the obvious: does dyspnoea really matter in heart failure?Milton Packer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2020
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia MimeticsMilton Packer
Hospitals|December 20, 1987
Data processing budgets jump during 1987C Packer
European Journal of Heart Failure|February 28, 2023
Dosing of iron supplementation for iron-deficient patients with heart failure: should we prefer more intensive or less intensive repletion targets?Milton Packer
American Journal of Nephrology|May 26, 2023
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal AnemiaMilton Packer
Diabetes, Obesity & Metabolism|March 31, 2026
Concurrence of the Core Mechanistic Tenets of the American Heart Association Statement on the Cardiovascular-Kidney-Metabolic Syndrome and the Adipokine Hypothesis of Heart Failure With Preserved Ejection FractionMilton Packer
Pageof 480

Showing results (271-280 of 4,797) with videos related to

Sort By:
Pageof 480
Circulation|October 1, 1985
Sudden unexpected death in patients with congestive heart failure: a second frontierM Packer
Journal of Cardiovascular Pharmacology and Therapeutics|June 23, 2017
Response by Dr Packer to the Letter of Dr BlankfieldMilton Packer
Circulation. Cardiovascular Quality and Outcomes|April 7, 2018
Does a Target Dose or a Target Heart Rate Matter to Outcomes When Prescribing β-Blockers to Patients With Chronic Heart Failure?Milton Packer
Circulation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM Packer
European Heart Journal|June 26, 2018
Questioning the obvious: does dyspnoea really matter in heart failure?Milton Packer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2020
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia MimeticsMilton Packer
Hospitals|December 20, 1987
Data processing budgets jump during 1987C Packer
European Journal of Heart Failure|February 28, 2023
Dosing of iron supplementation for iron-deficient patients with heart failure: should we prefer more intensive or less intensive repletion targets?Milton Packer
American Journal of Nephrology|May 26, 2023
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal AnemiaMilton Packer
Diabetes, Obesity & Metabolism|March 31, 2026
Concurrence of the Core Mechanistic Tenets of the American Heart Association Statement on the Cardiovascular-Kidney-Metabolic Syndrome and the Adipokine Hypothesis of Heart Failure With Preserved Ejection FractionMilton Packer
Pageof 480